Baboon as a nonhuman primate model for vaccine studies

Vaccine

Volumn 24, Issue 21, 2006, Pages 4622-4624

  Murthy, Krishna K ^a   Salas, Mary T ^a   Carey, Kenneth D ^a   Patterson, Jean L ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Baboons; Candidate vaccines; Immunogenicity; Nonhuman primates

Indexed keywords

CANCER VACCINE; CONTRACEPTIVE VACCINE; GONADORELIN; HEPATITIS C VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VACCINE;

ARTICLE; BABOON; CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOGENICITY; INFERTILITY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ANIMALS; MODELS, ANIMAL; PAPIO; VACCINES;

EID: 33646839288     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.047     Document Type: Article

References (27)

1. Stephens D.M., Eichberg J.W., Haigwood N.L., Steimer K.S., Davis D., and Lachmann P.J. Antibodies are produced to the variable regions of the external envelope glycoprotein of human immunodeficiency virus type 1 in chimpanzees infected with the virus and baboons immunized with a candidate recombinant vaccine. J Gen Virol 73 (1992) 1099-1106
2. Haigwood N.L., Nara P.L., Brooks E., Van Nest G.A., Ott G., Higgins K.W., et al. Native but not denatured recombinant human immuno-deficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J Virol 66 1 (1992) 172-182
3. Powell M.F., Cleland J.L., Eastman D.J., Lim A., Murthy K., Newman M.J., et al. Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboons. AIDS Res Hum Retroviruses 11 5 (1995) 661
4. Anderson K.P., Lucas C., Hanson C.V., Londe H.F., Izu A., Gregory T., et al. Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1. J Infect Dis 160 6 (1989) 960-969
5. Anderson K.P., Lucas C., Hanson C.V., Londe H.F., Izu A., Gregory T., et al. Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1. J Infect Dis 160 (1989) 960-969
6. Leng L., Srivastava I.K., Kan E., Legg H., Sun Y., Greer C., et al. Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen. AIDS 18 7 (2004) 991-1001
7. Irwin M.J., Laube L.S., Lee V., Austin M., Chada S., Anderson C.G., et al. Direct injection of a recombinant retroviral vector induces human immuno- deficiency virus-specific immune responses in mice and nonhuman primates. J Virol 68 8 (1994) 5036-5044
8. Casirmir D.R., Tang A., Chen L., Fu T.M., Evans R.K., Davies M.E., et al. Vaccine induced immunity in baboons by using DNA and replication incompetent adenovirus Type 5 vectors expressing a human immunodeficiency virus Type 1 gag gene. J Virol 77 13 (2003) 7663-7668
9. Locher C.P., Witt S.A., Ashlock B.M., Polacino P., Hu S.L., Shiboski S., et al. Human immunodeficiency virus type 2 DNA vaccine provides partial protein protection from acute baboon infection. Vaccine 22 (2004) 2261-2272
10. Murthy K, Salas M. Maternal vaccination strategy for prevention of RSV infection in infants. In: Proceedings of the XIIth International Congress of Virology. 27th July to 1 August 2002, Paris France.
11. Murthy K, Salas MT, Rice KS, Carey, KD, Welliver R. Immune response to RSV in experimentally infected baboons. RSV Symposium 2003, 6-11 November 2003, Stone Mountain, GA.
12. Jeong S.H., Qiao M., Nascimbeni M., Hu Z., Rehermann B., Murthy K., et al. Immunization with Hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates. J Virol 78 13 (2004) 6995-7003
13. Finstad C., Wang C.Y., Kowalski J., Zhang M., Li M.L., Li X.M., et al. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy. Vaccine 22 (2004) 1300-1313
14. Stevens V.C. Use of synthetic peptides as immunogens for developing a vaccine against human chorionic gonadotropin. Ciba Found Symp 119 (1986) 200-225
15. Isahakia M.A., and Bambra C.S. Anti-sperm and anti-ovum vaccines: the selection of candidate antigens and the outcome of preclinical studies. Scand J Immunol Suppl 11 (1992) 118-122
16. Reddi P.P., Castillo J.R., Klotz K., Flickinger C.J., and Herr J.C. Production in Escherichia coli, purification and immunogenicity of acrosomal protein SP-10, a candidate contraceptive vaccine. Gene 147 2 (1994) 189-1995
17. Yole D.S., Pemberton R., Reid G.D., and Wilson R.A. Protective immunity to Schistosoma mansoni induced in the olive baboon papio anubis by the irradiated cercaria vaccine. Parasitology 112 (1996) 37-46
18. Capron A., Riveau G., Grzych J.M., Boulanger D., Capron M., and Pierce R. Development of a vaccine strategy against human and bovine schistosomiasis. Trop Geogr Med 46 4 (1994) 242-246
19. Sturrock R.F., Butterworth A.E., Houba V., Cottrell B.J., Kimani R., Joseph M., et al. Attempts to manipulate specific responses to induce resistance to Schistosoma mansoni in Kenyan baboons (Papio anubis). J Helminthol 59 2 (1985) 175-186
20. Hong H.J., Lee J.W., Park S.S., Kang Y.J., Chang S.Y., Kim K.M., et al. A humanized anti-4-1BB monoclonal antibody suppresses antigen-induced humoral immune response in nonhuman primates. J Immunother 23 6 (2000) 613-621
21. Wang C.Y., Shen M., Tam G., Fang X.D., Ye J., Shen F., et al. Synthetic AIDS vaccine by targeting HIV receptor. Vaccine 21 (2002) 89-97
22. Barnett S.W., Murthy K.K., Herndier B.G., and Levy J.A. An AIDS like condition induced in baboons by HIV-2. Science 266 (1994) 642-646
23. Locher C.P., Witt S.A., Herndier B.G., Tenner-Racz K., Racz P., and Levy J.A. Transient virus infection and pathogenesis of a new HIV type 2 isolate, UC12, in baboons. AIDS Res Hum Retroviruses 14 (1998) 79-92
24. Paoletti L.C., Pinel J., Kennedy R.C., and Kasper D.L. Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate. J Infect Dis 181 2 (2000) 653-659
25. Shearer M.H., Lucas A.H., Anderson P.W., Carey K.D., Jenson H.B., Chanh T.C., et al. The baboon as a nonhuman primate model for assessing the effects of maternal immunization with Haemophilus influenzae type b polysaccharide vaccines. Infect Immun 65 8 (1997) 3267-3270
26. Granoff D.M., McHugh Y.E., Raff H.V., Mokatrin A.S., and Van Nest G.A. MF59 adjuvant enhances antibody responses of infant baboons immunized with haemophilus influenzae type b and neisseria meningititis group c oligosaccharide-CRM197 conjugate vaccine. Infect Immun 65 5 (1997) 1710-1715
27. Traquina P., Morandi M., Contorni M., and Van Nest N. MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates. J Infect Dis 174 6 (1996) 1168-1175